These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6110709)

  • 21. Abnormal neuromuscular transmission in an infantile myasthenic syndrome.
    Albers JW; Faulkner JA; Dorovini-Zis K; Barald KF; Must RE; Ball RD
    Ann Neurol; 1984 Jul; 16(1):28-34. PubMed ID: 6087719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrate-induced impairment of neuromuscular transmission in human and experimental autoimmune myasthenia gravis.
    Wirguin I; Brenner T; Shinar E; Argov Z
    Ann Neurol; 1990 Mar; 27(3):328-30. PubMed ID: 2158269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of plasmapheresis on neuromuscular transmission in myasthenia gravis].
    De Léan J
    Union Med Can; 1983 Jan; 112(1):9-13. PubMed ID: 6301126
    [No Abstract]   [Full Text] [Related]  

  • 24. The kinetics of transmitter release in myasthenia gravis. I. An electrophysiological analysis of the storage of transmitter.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1972; 12(5):443-88. PubMed ID: 4350884
    [No Abstract]   [Full Text] [Related]  

  • 25. [Neurophysiological testing in myasthenia syndromes].
    Kostera-Pruszczyk A; Rowińska-Marcińska K; Emeryk-Szajewska B
    Neurol Neurochir Pol; 2003; 37(1):161-72. PubMed ID: 12910838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenia in frogs immunized against cholinergic-receptor protein.
    Nastuk WL; Niemi WD; Alexander JT; Chang HW; Nastuk MA
    Am J Physiol; 1979 Jan; 236(1):C53-7. PubMed ID: 219703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A serum factor blocking neuromuscular transmission in myasthenia gravis: electrophysiological study with intracellular microelectrodes (author's transl)].
    Shibuya N
    Rinsho Shinkeigaku; 1978 Apr; 18(4):177-84. PubMed ID: 212240
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of electrophysiological response to thymectomy in patients with myasthenia gravis.
    Witoonpanich R
    J Med Assoc Thai; 2004 Nov; 87(11):1301-3. PubMed ID: 15825703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choline acetyltransferase and acetylcholinesterase. Their role in the causes of myasthenia gravis.
    Gentner DR; Rosenberg RN
    Arch Neurol; 1972 Dec; 27(6):521-5. PubMed ID: 4343459
    [No Abstract]   [Full Text] [Related]  

  • 30. Bringing life into focus. An overview of myasthenia gravis.
    Johnson J
    Adv Nurse Pract; 2008 Mar; 16(3):69-73, 82-3. PubMed ID: 19999509
    [No Abstract]   [Full Text] [Related]  

  • 31. A reassessment of the neurophysiological evidence for a presynaptic defect in myasthenia gravis.
    Bergmans J; Fannes-Breselow CF; Gribomont B
    Electromyogr Clin Neurophysiol; 1976; 16(4):337-51. PubMed ID: 187402
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of passive transfer of myasthenic serum on mechanical, electrical and neuromuscular transmission properties of mouse skeletal muscle.
    Losavio A; Muchnik S; Panizza M; Sica RE; Jauregui WO
    Medicina (B Aires); 1989; 49(1):7-13. PubMed ID: 2561004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Facilitation phenomenon in electrophysiological diagnosis of myasthenia gravis].
    Emeryk B; Rowińska K; Michalska T
    Neurol Neurochir Pol; 1991; 25(2):156-62. PubMed ID: 1656295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome.
    Heath JP; Ewing DJ; Cull RE
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):436-9. PubMed ID: 3361337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC; Johns RJ
    Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
    [No Abstract]   [Full Text] [Related]  

  • 36. Disorders of neuromuscular transmission other than myasthenia gravis.
    Swift TR
    Muscle Nerve; 1981; 4(4):334-53. PubMed ID: 6114428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurophysiological aspects of diagnosis in neuromuscular transmission defects--an update.
    Stålberg E
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():377-85. PubMed ID: 10689484
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of temperature on neuromuscular transmission in myasthenia gravis.
    Ricker K; Hertel G; Stodieck S
    J Neurol; 1977 Nov; 216(4):273-82. PubMed ID: 72810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.